Manganese superoxide dismutase (MnSOD) is a critical antioxidant enzyme that protects against superoxide anion generated as a consequence of normal cellular respiration as well as 
Introduction
Oxygen free radicals produced as a by-product of aerobic metabolism as well as the inflammatory response are detoxified through the action of the potent, cytoprotective antioxidant enzyme, manganese superoxide dismutase (MnSOD). The physiological significance of MnSOD was demonstrated when two groups independently ablated the MnSOD gene producing SOD null mice. These mutant mice all die within 10 days of birth with dilated cardiomyopathy, steatosis in liver and skeletal muscle as well as metabolic acidosis (21, 26) . In addition, it has become intuitively obvious that the endogenous cytoprotective potential of MnSOD (39, 38) is achieved through transcriptional induction by a variety of pro-inflammatory mediators as an adaptive response to inflammation. We have previously shown that stimulus-dependent transcriptional induction is mediated through the cooperative interaction between cis-elements and their cognate trans-acting factors within the MnSOD promoter and a complex intronic enhancer element (28) .
Many of the approaches that attempt to address the underlying mechanisms controlling transcriptional regulation involve in vitro strategies to assess the interaction of trans-acting factors with their cognate binding sites. Such methodologies include electromobility gel shift assays (EMSA) (12) and in vitro footprinting studies (30) . In vitro studies are unfortunately performed in the absence of the cellular milieu and, most importantly, without the influence of the nucleoprotein structure. Thus these methods only provide circumstantial evidence to support the physiological relevance and validity of in vivo protein-DNA interactions. Studies undertaken in vitro at ionic conditions, pH, and protein/DNA concentrations outside the physiologic range dramatically affect the specificity of protein-DNA complexes, potentially allowing non-specific interactions to predominate. Furthermore, in vitro studies are not performed in the context of a complex genome where the size of the primary recognition sequence (4, 35, 36) and the local chromatin environment help to mediate the specificity of protein/DNA interactions (5) .
The abundance of studies utilizing transient transfection assays has provided extensive information on promoter and transcription factor structure and function leading to the derivation of our present conceptual models of gene regulation. Transient expression studies presumably recreate the physiologically appropriate cellular environment to insure most levels of specificity necessary for valid intracellular protein/DNA complex formation. Recently, Lee et al. (23) developed a methodology which complements transient transfection assays, termed protein position identification with nuclease tail or PIN*POINT. This methodology provides a mechanism to assess, in vivo, whether a specific trans-acting factor can indeed be placed directly at the scene of a putative binding sequence in cells. An expression vector encoding a chimera of a transcription factor and the nuclease cleavage domain of type IIS endonuclease FokI (18) , is co-transfected into mammalian cells with a target plasmid containing the cognate DNA binding site for the chimeric trans-acting factor. This method has been employed transiently, with a variety of transcription factor/FokI nuclease chimeras to demonstrate specific protein/DNA binding through adjacent nuclease cleavage (23, 22, 24, 25, 17) . PIN*POINT can thus be an ideal approach to verify, in vivo, the identity of potential transcription factor candidates for functionally relevant cis-acting elements.
Unfortunately, the interpretation of transient transfection results is also limited by the inherent structure of plasmid DNA in transfected cells. Smith and Hager (32) have reviewed transcriptional regulation of mammalian genes in vivo and convincingly purported that although non-replicating DNA may form structures, which include nucleosome deposition, the final structures are not organized in a manner similar to endogenous chromatin. This critical argument is best exemplified by the studies of Archer and colleagues (1, 2) which demonstrated that transfected, non-replicating templates bind transcription factors constitutively, while these same factors will interact with endogenous sites only when the chromatin has been appropriately remodeled. Additionally, recent studies have underscored the central importance of chromatin structure (13, 40) and remodeling (14, 10, 11, 34) with respect to the specificity of trans-acting factor binding and the subsequent regulation of gene expression.
To address some of the limitations in methods employed thus far to study gene expression, we present data which improves and extends the PIN*POINT methodology allowing for detection of specific trans-acting factor binding on an endogenous locus. Our laboratory has previously identified ten basal protein binding sites on the manganese superoxide dismutase (MnSOD) promoter by dimethyl sulfate (DMS) in vivo footprinting (20) . A number of these cisacting elements show significant sequence similarity to the consensus Sp1-binding sequence (9) .
We have thus employed a chimeric Sp1-FokI nuclease expression vector to identify endogenous binding sites occupied by Sp1 in vivo. Furthermore, using site-directed mutagenesis, we evaluated the functional importance of Sp1 at these binding sites during inducible expression of MnSOD by pro-inflammatory stimuli.
Materials and Methods

Cell culture
L2 cells, a rat pulmonary epithelial-like cell line (ATCC CCL 149), were grown in Ham's modified F12K medium (GIBCO) with 10% fetal bovine serum (Flow Laboratories), ABAM (penicillin G 100 U/ml, streptomycin 0.1 mg/ml, amphotericin B 0.25 mg/ml, Sigma Corp) and 4 mM glutamine at 37 o C in room air, 5% CO 2 .
Chromatin immunoprecipitation (ChIP)
L2 cells grown to 100% confluency were crosslinked with 1% formaldehyde for 10 min at room temperature and quenched with 125 mM glycine (3, 27 PCR products were size fractionated on a 6% denaturing polyacrylamide gel, electrotransferred to a nylon membrane, and covalently cross-linked to the membrane by UV irradiation (8) . Two oligos, 5'-CGTCCGCTTGGACACAGCTAGGCGCTGACC-3' and 5'-GGCTTCCCGGAGG-AAAGTCTCTGGGGCTTTCC-3', were used to make 32 P radioisotope probes as described (29) for visualization of the top and bottom strands, respectively.
Site-directed mutagenesis and construction of expression vectors
The MnSOD promoter from -420 to +74 relative to the transcriptional start site was used to construct wild type and each of the mutant clones in a human growth hormone expression plasmid also containing the rat MnSOD intronic enhancer element (28) . PCR-based site-directed mutagenesis was used to create each mutant clone as previously described (16) . PCR primers used to produce mutated binding sites (mutated base pairs underlined) were as follows: Biolabs) was used to produce a blunt-ended PCR product, which was cloned into the pPCRscript sk(+) plasmid using PCR-Script Amp Cloning Kit (Stratagene). The plasmid was then digested
with Hind III and Xba I, and the insert was cloned into a Hind III and Xba I pre-digested promoterless, pUC 12-based human growth hormone expression vector pØGH (Nichols Institute Diagnostics), which also contained the rat MnSOD intronic enhancer element (from +1268 to +2187) defined by our laboratory (28) . The final mutagenesis plasmids were verified by sequencing.
Transient transfection with vectors containing Sp1 mutations in the MnSOD promoter
To control for transfection efficiency, transfections were carried out using a batch transfection method as described previously (28) as well as co-transfection with pcDNA 3.1/HisB/LacZ (Invitrogen). Cells were grown as monolayers in 150 mm tissue culture plates until 70-90% confluent. The cells were transfected with 10 µg of each expression vector using the DEAE-dextran method (19) . After 24 h, cells from each 150 mm were trypsinized and plated onto four separate 100 mm tissue culture plates. 24 h later inflammatory mediators were added to each plate with final concentrations of 0.5 µg/ml Escherichia coli lipopolysaccharide (LPS, E.
coli serotype 055:B5, Sigma Corp), 10 ng/ml TNF-α (a gift from Genentech), or 2 ng/ml IL-1β
(a gift from the National Cancer Institute). Total RNA for northern analysis was isolated 24 h after treatment by the acid guanidinium thiocyanate-phenol-chloroform extraction method described by Chomczynski and Sacchi (7) with modifications (28). RNA was size-fractionated on a 1% agarose formaldehyde gel and electrotransferred to a charged nylon membrane (Zetabind) and UV cross-linked. Membranes were hybridized with 32 P-labeled human growth hormone (hGH), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probes made by primer extension and subjected to autoradiography. GAPDH was used as the RNA loading control. NIH image was used to analyze the signal density of messages.
Results
Localization of Sp1 to the MnSOD promoter by chromatin immunoprecipitation (ChIP)
As summarized in Figure 1A , we have previously used DMS in vivo footprinting coupled with ligation-mediated PCR (LMPCR) to identify ten basal protein binding sites on the MnSOD promoter (20) . A computer analysis of these binding sites shows that a subset of these basal binding sites (sites I-V) have a high degree of similarity to the consensus DNA binding sequence of Sp1 (9), GKLF (31) as well as other GC-box binding proteins (6, 37) . To demonstrate that Sp1 does interact with sequences in this region we utilized chromatin immunoprecipitation (ChIP, 27) with Sp1 specific antibodies (3). Figure 1B illustrates the specificity of the chimeric cleavage in that this ~140 bp is extremely GC rich providing numerous opportunities for non-specific Sp1 interaction, yet only one cleavage is observed adjacent to the previously localized binding site. Interestingly, we observed two cleavage sites near site IX, the first occurring 4 bases 5' to the potential binding site whereas the second observed cleavage was 29 bases 5' to the site IX. On closer analysis of our previous in vivo footprinting data we were able to identify additional putative protein contacts 3' to this latter cleavage site, which may define an additional in vivo Sp1 binding site.
Sp1 sites important to stimulus-dependent MnSOD gene expression
To evaluate the functional importance of Sp1 binding sites, III, V, and IX, defined in vivo by PIN*POINT analysis, we employed PCR-based site-directed mutagenesis to construct mutant clones of these sites. The residues chosen for mutagenesis were based on the protein contacts originally defined by our DMS in vivo footprinting (20) . The MnSOD promoter from -420 to +74 was subcloned into a human growth hormone reporter vector, also containing the MnSOD enhancer from positions +1268 to +2187 (28) . Reporter vectors containing wild type and sitespecific promoter mutants were transiently transfected into L2 cells and stimulated with proinflammatory mediators. Reporter gene expression levels were evaluated by northern analysis.
Transfection efficiency was evaluated by co-trasnfection pcDNA 3.1/HisB/LacZ and found to be equal between independent experiments. For comparison, the mutagenesis results for site I are shown as a negative control ( Figure 3A) . Representative results for sites V and IX are shown in 13 Figure 3B. The data demonstrates that Sp1 sites V and IX play relevant functional roles in the induction of MnSOD gene expression by pro-inflammatory stimuli. In addition, we also generated reporter plasmids, which contained mutations at both sites V and IX as shown in Figure 3C illustrating an additional loss of stimulus-dependent induction. Mutagenesis of site III had no effect on either basal or stimulated reporter gene expression (data not shown).
Discussion
Our previous in vivo footprinting studies have defined the existence of 10 basal protein binding sites (20) within the proximal MnSOD promoter ( Figure 1A ). Our original results (20) also included in vitro footprinting analysis using commercially available Sp1 protein, which implied that Sp1 could interact with sites I-V. Unfortunately, at the time no methodologies existed to unequivocally demonstrate the association of Sp1 with the potential binding sites in the promoter within the context of the nucleus.
The development of PIN*POINT analysis by Chung and co-workers (23) provided the first avenue to address the critical question of trans-acting factor occupancy within the nucleoprotein environment. The PIN*POINT strategy however, as originally described (23), involves detection of protein/DNA interactions only on a co-transfected target plasmid.
Unfortunately, mounting evidence would indicate that regulatory sequences on transiently transfected plasmid DNA may not be a suitable model for studies on the regulation of the endogenous gene given the lack of appropriate chromatin structure on transfected DNA (32).
The importance of chromatin structure is of special significance to MnSOD regulation in that we have previously demonstrated that both functionally relevant promoter sequences as well as the intronic enhancer element reside in independent DNase I hypersensitive sites (20) . We therefore modified the original PIN*POINT methodology to directly demonstrate the occupancy of a ciselement by a specific trans-acting factor within the context of the endogenous chromatin structure.
The goals of these studies were to establish whether Sp1 could truly interact with MnSOD 
